TrialReach raises $13.5M for clinical trial-patient matching service

TrialReach raised $13.5 million in a Series B round to scale up its clinical trial discovery platform. The system is designed to accelerate enrollment into clinical research by matching patients to appropriate trials. London-based TrialReach takes a multipronged approach to the task, the first step of which is to convert jargon-heavy trial protocols into layman's terms. Smedvig Capital led the round. Release | More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.